"At the start of this year, a new 7.2mg dose was approved, with people losing an average of 18.7 per cent of their starting body weight." However, the Wegovy pill is the first of multiple GLP-1 pills which are likely to hit the market over the next few years
You will also find guidance on higher-concentration vials , syringe conversion math , and how to transition between different GLP-1 medications if your provider recommends a change
Then, if the patient qualifies, they can get a prescription for a number of weight loss drugs, including: Ozempic, Wegovy, Mounjaro and generic
Patients on Zepbound lost an average of 15%, 19.5%, and 20.9% of their body weight at the respective doses, compared to 3.1% average weight loss in participants who received the placebo
You would need a 3ml syringe for the higher doses, which reduces measurement precision because the graduation marks are spaced further apart